Clinical trial
A Study Of The Safety And Effectiveness Of A New Treatment For Allergic…
NCT00375596 · Bausch & Lomb Incorporated, Industry · Withdrawn
Key facts
| NCT number | NCT00375596 |
|---|---|
| Title | A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis |
| Official title | Study Withdrawn Prior to Determining Official Title |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Allergic Conjunctivitis |
| Intervention type | Drug |
| Interventions | Ketotifen/vasoconstrictor |
| Enrollment | 0 |
| First posted | Sep 13, 2006 |
| Last update posted | Feb 20, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: